148 related articles for article (PubMed ID: 19146891)
1. Factors responsible for plaque formation of A/duck/Siberia/272/1998 (H13N6) influenza virus on MDCK cells.
Tsuda Y; Isoda N; Sakoda Y; Kida H
Virus Res; 2009 Mar; 140(1-2):194-8. PubMed ID: 19146891
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of reassortant influenza A viruses propagated in serum-free cultured MDCK-SF1 cells.
Voeten JT; Claas EC; Brands R; Palache AM; van Scharrenburg GJ; Rimmelzwaan GF; Osterhaus AD
Dev Biol Stand; 1999; 98():77-87; discussion 89-90. PubMed ID: 10494961
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of influenza virus infection by targeting genome conserved region with non-natural nucleic acid.
Takahashi T; Ohzawa T; Sawada S; Kato N; Goto N; Nakamura S; Yasunaga T; Kaihatsu K
Nucleic Acids Symp Ser (Oxf); 2009; (53):285-6. PubMed ID: 19749372
[TBL] [Abstract][Full Text] [Related]
4. Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells.
Govorkova EA; Matrosovich MN; Tuzikov AB; Bovin NV; Gerdil C; Fanget B; Webster RG
Virology; 1999 Sep; 262(1):31-8. PubMed ID: 10489338
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).
Youil R; Kiseleva I; Kwan WS; Szymkowiak C; Toner TJ; Su Q; Klimov A; Rudenko L; Shaw AR
Virus Res; 2004 Jun; 102(2):165-76. PubMed ID: 15084398
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of influenza virus replication in Vero and MDCK cell lines.
Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
[TBL] [Abstract][Full Text] [Related]
7. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
[TBL] [Abstract][Full Text] [Related]
8. The substitution V379I in PA protein attenuates the pathogenicity of influenza A (H1N1) pdm09 viruses in mice.
Chen Y; Zhu W; Bai T; Zou X; Zhang S; Sun Y; Li X; Xiang X; Zhao Q; Huang C; Chen T; Wang D; Shu Y
Sci China Life Sci; 2017 Sep; 60(9):1044-1046. PubMed ID: 28293812
[No Abstract] [Full Text] [Related]
9. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation.
Saito T; Nakaya Y; Suzuki T; Ito R; Saito T; Saito H; Takao S; Sahara K; Odagiri T; Murata T; Usui T; Suzuki Y; Tashiro M
J Med Virol; 2004 Oct; 74(2):336-43. PubMed ID: 15332284
[TBL] [Abstract][Full Text] [Related]
10. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
[TBL] [Abstract][Full Text] [Related]
11. Reliable universal RT-PCR assays for studying influenza polymerase subunit gene sequences from all 16 haemagglutinin subtypes.
Li OT; Barr I; Leung CY; Chen H; Guan Y; Peiris JS; Poon LL
J Virol Methods; 2007 Jun; 142(1-2):218-22. PubMed ID: 17324474
[TBL] [Abstract][Full Text] [Related]
12. Influenza A virus derived from persistently virus-infected cells shows attenuated cytotoxicity in cultured cells but virulent pathogenicity in mice.
Jaber Hossain M; Mori I; Liu B; Kimura Y
Microb Pathog; 2008 May; 44(5):417-25. PubMed ID: 18162362
[TBL] [Abstract][Full Text] [Related]
13. Maturation efficiency of viral glycoproteins in the ER impacts the production of influenza A virus.
Ueda M; Yamate M; Du A; Daidoji T; Okuno Y; Ikuta K; Nakaya T
Virus Res; 2008 Sep; 136(1-2):91-7. PubMed ID: 18550190
[TBL] [Abstract][Full Text] [Related]
14. Tyr82 Amino Acid Mutation in PB1 Polymerase Induces an Influenza Virus Mutator Phenotype.
Naito T; Shirai K; Mori K; Muratsu H; Ushirogawa H; Ohniwa RL; Hanada K; Saito M
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462570
[TBL] [Abstract][Full Text] [Related]
15. A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells.
Takahashi H; Hamazaki H; Habu Y; Hayashi M; Abe T; Miyano-Kurosaki N; Takaku H
FEBS Lett; 2004 Feb; 560(1-3):69-74. PubMed ID: 14988000
[TBL] [Abstract][Full Text] [Related]
16. Transmission of equine influenza virus to dogs.
Crawford PC; Dubovi EJ; Castleman WL; Stephenson I; Gibbs EP; Chen L; Smith C; Hill RC; Ferro P; Pompey J; Bright RA; Medina MJ; Johnson CM; Olsen CW; Cox NJ; Klimov AI; Katz JM; Donis RO
Science; 2005 Oct; 310(5747):482-5. PubMed ID: 16186182
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotides derived from the packaging signal at the 5' end of the viral PB2 segment specifically inhibit influenza virus in vitro.
Giannecchini S; Clausi V; Nosi D; Azzi A
Arch Virol; 2009; 154(5):821-32. PubMed ID: 19370391
[TBL] [Abstract][Full Text] [Related]
18. Resistance to influenza A virus infection in transformed cell lines expressing an anti-PB2 monoclonal antibody.
Fujimoto Y; Ozaki K; Maeda M; Nishijima K; Takakuwa H; Otsuki K; Kida H; Ono E
Vet J; 2013 Nov; 198(2):487-93. PubMed ID: 24140339
[TBL] [Abstract][Full Text] [Related]
19. Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine.
Brands R; Visser J; Medema J; Palache AM; van Scharrenburg GJ
Dev Biol Stand; 1999; 98():93-100; discussion 111. PubMed ID: 10494962
[TBL] [Abstract][Full Text] [Related]
20. Isolation and molecular characterization of equine H3N8 influenza viruses from pigs in China.
Tu J; Zhou H; Jiang T; Li C; Zhang A; Guo X; Zou W; Chen H; Jin M
Arch Virol; 2009; 154(5):887-90. PubMed ID: 19396578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
